Tolvaptan
RxNorm 358257
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 358257 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: tolvaptan.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
FNPrescribable
Full form of descriptor (FN):
Product containing tolvaptan (medicinal product)
(Atom ID: 9263528)
INPrescribable
Ingredient (IN):
Tolvaptan
(Atom ID: 2969476)
PTPrescribable
Designated preferred name (PT):
Tolvaptan
(Atom ID: 3058497)
FNPrescribable
Full form of descriptor (FN):
Tolvaptan (substance)
(Atom ID: 3058499)
PTPrescribable
Designated preferred name (PT):
Tolvaptan-containing product
(Atom ID: 10822052)
Patient Education
Tolvaptan (kidney disease)
Tolvaptan (Jynarque) is used to slow the worsening of kidney function in certain patients with autosomal dominant polycystic kidney disease (ADPKD; a certain type of inherited kidney disease). Tolvaptan (Jynarque) is in a class of medications called vasopressin V2 receptor antagonists. It works by increasing the amount of water released from the body as urine and decreases the growth of cysts in the kidneys. Removing fluid from the body and slowing the growth of cysts helps to slow the worsening of kidney function. Tolvaptan is also available as a tablet (Samsca) to treat low blood levels of sodium in people who have heart failure or certain other conditions. This monograph only gives information about tolvaptan tablets (Jynarque) to slow the worsening of kidney function in patients with ADPKD. If you are using this medication to treat low levels of sodium in the blood, read the monograph entitled tolvaptan (low blood sodium).
[Learn More]
Tolvaptan (low blood sodium)
Tolvaptan (Samsca) is used to treat hyponatremia (low levels of sodium in the blood) in people who have heart failure (condition in which the heart cannot pump enough blood to all parts of the body), syndrome of inappropriate antidiuretic hormone (SIADH; condition in which the body produces too much of a certain natural substance that causes the body to retain water) or other conditions. Tolvaptan is in a class of medications called vasopressin V2 receptor antagonists. It works by increasing the amount of water released from the body as urine. Removing fluid from the body helps to increase the level of sodium in the blood.
[Learn More]
* Please review the disclaimer below.